{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:54:19Z","timestamp":1782935659811,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T00:00:00Z","timestamp":1442448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s11886-015-0652-2","type":"journal-article","created":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T05:46:56Z","timestamp":1442468816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Autonomic Modulation in Heart Failure: Ready for Prime Time?"],"prefix":"10.1007","volume":"17","author":[{"given":"Mark E.","family":"Dunlap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Hauptman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,17]]},"reference":[{"key":"652_CR1","first-page":"435","volume":"6","author":"AM Gossage","year":"1913","unstructured":"Gossage AM, Braxton Hicks JA. On auricular fibrillation. Q J Med. 1913;6:435\u201340.","journal-title":"Q J Med"},{"issue":"10","key":"652_CR2","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/hrt.37.10.1022","volume":"37","author":"F Waagstein","year":"1975","unstructured":"Waagstein F et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975;37(10):1022\u201336.","journal-title":"Br Heart J"},{"issue":"2","key":"652_CR3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10741-010-9190-6","volume":"16","author":"S Bibevski","year":"2011","unstructured":"Bibevski S, Dunlap ME. Evidence for impaired vagus nerve activity in heart failure. Heart Fail Rev. 2011;16(2):129\u201335.","journal-title":"Heart Fail Rev"},{"issue":"5","key":"652_CR4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1152\/jappl.1975.39.5.801","volume":"39","author":"PG Katona","year":"1975","unstructured":"Katona PG, Jih F. Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control. J Appl Physiol. 1975;39(5):801\u20135.","journal-title":"J Appl Physiol"},{"issue":"3","key":"652_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1071-9164(96)80039-X","volume":"2","author":"P Ponikowski","year":"1996","unstructured":"Ponikowski P et al. Heart rhythms, ventricular arrhythmias, and death in chronic heart failure. J Card Fail. 1996;2(3):177\u201383.","journal-title":"J Card Fail"},{"issue":"1","key":"652_CR6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/europace\/eut311","volume":"16","author":"KH Kuck","year":"2014","unstructured":"Kuck KH et al. New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace. 2014;16(1):109\u201328.","journal-title":"Europace"},{"key":"652_CR7","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/eurheartj\/ehv087","volume":"36","author":"JS Floras","year":"2015","unstructured":"Floras JS, Ponikowski P. The sympathetic\/parasympathetic imbalance in heart failure with reduced ejection fraction. Eur Heart J. 2015;36:1974\u201382. This is a thorough review of the autonomic nervous system in HF, including pathways and mechanisms known to be abnormal in HF.","journal-title":"Eur Heart J"},{"issue":"5","key":"652_CR8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1388-9842(03)00163-6","volume":"5","author":"JN Cohn","year":"2003","unstructured":"Cohn JN et al. Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). Eur J Heart Fail. 2003;5(5):659\u201367.","journal-title":"Eur J Heart Fail"},{"issue":"22","key":"652_CR9","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJM200105313442202","volume":"344","author":"Beta-Blocker Evaluation of Survival Trial Investigators","year":"2001","unstructured":"Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344(22):1659\u201367.","journal-title":"N Engl J Med"},{"issue":"9377","key":"652_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","volume":"362","author":"PA Poole-Wilson","year":"2003","unstructured":"Poole-Wilson PA et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362(9377):7\u201313.","journal-title":"Lancet"},{"issue":"6","key":"652_CR11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.mehy.2009.01.009","volume":"72","author":"EG Lipov","year":"2009","unstructured":"Lipov EG et al. A unifying theory linking the prolonged efficacy of the stellate ganglion block for the treatment of chronic regional pain syndrome (CRPS), hot flashes, and posttraumatic stress disorder (PTSD). Med Hypotheses. 2009;72(6):657\u201361.","journal-title":"Med Hypotheses"},{"issue":"5","key":"652_CR12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0002-8703(76)80078-6","volume":"92","author":"PJ Schwartz","year":"1976","unstructured":"Schwartz PJ, Stone HL, Brown AM. Effects of unilateral stellate ganglion blockade on the arrhythmias associated with coronary occlusion. Am Heart J. 1976;92(5):589\u201399.","journal-title":"Am Heart J"},{"issue":"Suppl A","key":"652_CR13","first-page":"107","volume":"7","author":"PJ Schwartz","year":"1986","unstructured":"Schwartz PJ, Zaza A. The rational basis and the clinical value of selective cardiac sympathetic denervation in the prevention of malignant arrhythmias. Eur Heart J. 1986;7(Suppl A):107\u201318.","journal-title":"Eur Heart J"},{"issue":"4","key":"652_CR14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00000539-200010000-00005","volume":"91","author":"J Mullenheim","year":"2000","unstructured":"Mullenheim J et al. Left stellate ganglion block has only small effects on left ventricular function in a wake dogs before and after induction of heart failure. Anesth Analg. 2000;91(4):787\u201392.","journal-title":"Anesth Analg"},{"issue":"15","key":"652_CR15","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370(15):1393\u2013401.","journal-title":"N Engl J Med"},{"issue":"3","key":"652_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","volume":"162","author":"JE Davies","year":"2013","unstructured":"Davies JE et al. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol. 2013;162(3):189\u201392.","journal-title":"Int J Cardiol"},{"issue":"2","key":"652_CR17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11897-013-0135-y","volume":"10","author":"AE Burchell","year":"2013","unstructured":"Burchell AE et al. Chemohypersensitivity and autonomic modulation of venous capacitance in the pathophysiology of acute decompensated heart failure. Curr Heart Fail Rep. 2013;10(2):139\u201346. This review summarizes the pathophysiological links between abnormalities of chemoreflexes in HF and activation of the sympathetic nervous system leading to decompensating HF.","journal-title":"Curr Heart Fail Rep"},{"issue":"1","key":"652_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/HYPERTENSIONAHA.111.00064","volume":"61","author":"JF Paton","year":"2013","unstructured":"Paton JF et al. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension. 2013;61(1):5\u201313.","journal-title":"Hypertension"},{"key":"652_CR19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1378\/chest.40.6.595","volume":"40","author":"K Nakayama","year":"1961","unstructured":"Nakayama K. Surgical removal of the carotid body for bronchial asthma. Dis Chest. 1961;40:595\u2013604.","journal-title":"Dis Chest"},{"issue":"Pt 2","key":"652_CR20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1113\/jphysiol.2013.266221","volume":"592","author":"NJ Marcus","year":"2014","unstructured":"Marcus NJ et al. Carotid body denervation improves autonomic and cardiac function and attenuates disordered breathing in congestive heart failure. J Physiol. 2014;592(Pt 2):391\u2013408.","journal-title":"J Physiol"},{"issue":"3","key":"652_CR21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1113\/expphysiol.2013.075580","volume":"99","author":"P Niewinski","year":"2014","unstructured":"Niewinski P et al. Dissociation between blood pressure and heart rate response to hypoxia after bilateral carotid body removal in men with systolic heart failure. Exp Physiol. 2014;99(3):552\u201361.","journal-title":"Exp Physiol"},{"issue":"8","key":"652_CR22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/CIRCULATIONAHA.107.760405","volume":"118","author":"B Olshansky","year":"2008","unstructured":"Olshansky B et al. Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation. 2008;118(8):863\u201371.","journal-title":"Circulation"},{"issue":"2","key":"652_CR23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10741-010-9195-1","volume":"16","author":"MY Desai","year":"2011","unstructured":"Desai MY et al. Pharmacologic modulation of parasympathetic activity in heart failure. Heart Fail Rev. 2011;16(2):179\u201393.","journal-title":"Heart Fail Rev"},{"issue":"4","key":"652_CR24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/01.CIR.71.4.797","volume":"71","author":"ME Dibner-Dunlap","year":"1985","unstructured":"Dibner-Dunlap ME et al. The long-term increase of baseline and reflexly augmented levels of human vagal-cardiac nervous activity induced by scopolamine. Circulation. 1985;71(4):797\u2013804.","journal-title":"Circulation"},{"issue":"2","key":"652_CR25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/hrt.76.2.137","volume":"76","author":"G Venkatesh","year":"1996","unstructured":"Venkatesh G et al. Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure. Heart. 1996;76(2):137\u201343.","journal-title":"Heart"},{"issue":"8","key":"652_CR26","doi-asserted-by":"crossref","first-page":"R908","DOI":"10.1152\/ajpregu.00102.2013","volume":"305","author":"RM Lataro","year":"2013","unstructured":"Lataro RM et al. Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure. Am J Physiol Regul Integr Comp Physiol. 2013;305(8):R908\u201316.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"652_CR27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ejhf.214","volume":"17","author":"A Chen","year":"2015","unstructured":"Chen A, Chen YM. Donepezil, a potential therapeutic agent for heart failure. Eur J Heart Fail. 2015;17(2):233.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"652_CR28","first-page":"152","volume":"76","author":"S Shimizu","year":"2012","unstructured":"Shimizu S et al. Medetomidine, an alpha(2)-adrenergic agonist, activates cardiac vagal nerve through modulation of baroreflex control. Circ J Off J Jpn Circ Soc. 2012;76(1):152\u20139.","journal-title":"Circ J Off J Jpn Circ Soc"},{"issue":"Suppl 1","key":"652_CR29","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.3949\/ccjm.78.s1.04","volume":"78","author":"HN Sabbah","year":"2011","unstructured":"Sabbah HN. Electrical vagus nerve stimulation for the treatment of chronic heart failure. Cleve Clin J Med. 2011;78 Suppl 1:S24\u20139.","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"652_CR30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCHEARTFAILURE.109.873968","volume":"2","author":"Y Zhang","year":"2009","unstructured":"Zhang Y et al. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail. 2009;2(6):692\u20139.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"652_CR31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.CIR.0000105721.71640.DA","volume":"109","author":"M Li","year":"2004","unstructured":"Li M et al. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation. 2004;109(1):120\u20134.","journal-title":"Circulation"},{"issue":"11","key":"652_CR32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.cardfail.2014.08.009","volume":"20","author":"RK Premchand","year":"2014","unstructured":"Premchand RK et al. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial. J Card Fail. 2014;20(11):808\u201316.","journal-title":"J Card Fail"},{"issue":"7","key":"652_CR33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/eurheartj\/ehu345","volume":"36","author":"F Zannad","year":"2015","unstructured":"Zannad F et al. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial. Eur Heart J. 2015;36(7):425\u201333.","journal-title":"Eur Heart J"},{"issue":"7","key":"652_CR34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehq391","volume":"32","author":"GM Ferrari De","year":"2011","unstructured":"De Ferrari GM et al. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J. 2011;32(7):847\u201355.","journal-title":"Eur Heart J"},{"issue":"4","key":"652_CR35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cardfail.2014.01.009","volume":"20","author":"PJ Hauptman","year":"2014","unstructured":"Hauptman PJ, Gottlieb SS. Clinical trial design in contemporary device studies in heart failure: is there a gold standard? J Card Fail. 2014;20(4):223\u20138.","journal-title":"J Card Fail"},{"issue":"6","key":"652_CR36","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ahj.2012.03.021","volume":"163","author":"PJ Hauptman","year":"2012","unstructured":"Hauptman PJ et al. Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF. Am Heart J. 2012;163(6):954\u201362. e1.","journal-title":"Am Heart J"},{"key":"652_CR37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijcard.2015.03.317","volume":"187","author":"M Chen","year":"2015","unstructured":"Chen M et al. Noninvasive vagus nerve stimulation: a novel promising modulator for cardiac autonomic nerve system dysfunction. Int J Cardiol. 2015;187:338\u20139.","journal-title":"Int J Cardiol"},{"issue":"9","key":"652_CR38","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2014.12.026","volume":"65","author":"S Stavrakis","year":"2015","unstructured":"Stavrakis S et al. Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation. J Am Coll Cardiol. 2015;65(9):867\u201375.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"652_CR39","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.hrthm.2014.12.014","volume":"12","author":"HF Tse","year":"2015","unstructured":"Tse HF et al. Thoracic spinal cord stimulation for heart failure as a restorative treatment (SCS HEART study): first-in-man experience. Heart Rhythm Off J Heart Rhythm Soc. 2015;12(3):588\u201395.","journal-title":"Heart Rhythm Off J Heart Rhythm Soc"},{"issue":"4","key":"652_CR40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jash.2012.04.004","volume":"6","author":"UC Hoppe","year":"2012","unstructured":"Hoppe UC et al. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens. 2012;6(4):270\u20136.","journal-title":"J Am Soc Hypertens"},{"issue":"6","key":"652_CR41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","volume":"3","author":"WT Abraham","year":"2015","unstructured":"Abraham WT et al. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction. JACC Heart Fail. 2015;3(6):487\u201396.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"652_CR42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cardfail.2010.09.004","volume":"17","author":"D Georgakopoulos","year":"2011","unstructured":"Georgakopoulos D et al. Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction. J Card Fail. 2011;17(2):167\u201378.","journal-title":"J Card Fail"},{"issue":"2","key":"652_CR43","doi-asserted-by":"crossref","first-page":"R418","DOI":"10.1152\/ajpregu.00463.2010","volume":"300","author":"T Durand Mde","year":"2011","unstructured":"Durand Mde T et al. Hemodynamic responses to aortic depressor nerve stimulation in conscious L-NAME-induced hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2011;300(2):R418\u201327.","journal-title":"Am J Physiol Regul Integr Comp Physiol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-015-0652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-015-0652-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-015-0652-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T17:26:30Z","timestamp":1567185990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-015-0652-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,17]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1007\/s11886-015-0652-2","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,17]]},"article-number":"103"}}